Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 449 followers
Latest posts
Last updated about 1 hour ago
Expert panel support for breakthrough medical devices: pilot programme
7 days ago
Expert panel support for breakthrough medical devices: pilot programme
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 18, Status: Authorised
6 days ago
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 33, Status: Authorised
6 days ago
Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine...
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 4, Status: Authorised
6 days ago
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation...
Quarterly System Demo - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 September 2026, 09:00 (CEST) to 17 September 2026, 11:30 (CEST)
5 days ago
Quarterly System Demo - Q3 2026, Online, European Medicines Agency, Amsterdam, the...
Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 8, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation...
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 41, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 26, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of...
Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of authorisation: 11/01/2017, Revision: 16, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of...
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 49, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Bexsero, meningococcal group B Vaccine (rDNA, component, adsorbed), Date of authorisation: 13/01/2013, Revision: 37, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Bexsero, meningococcal group B Vaccine...
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 5, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation...